As of Feb 24
| +0.45 / +3.85%|
The 5 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 22.00, with a high estimate of 28.00 and a low estimate of 15.00. The median estimate represents a +81.07% increase from the last price of 12.15.
The current consensus among 6 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.